STOCK TITAN

ARIDIS PHARMACEUTICAL INC (ARDS) Net Income by Year

ARDS

ARIDIS PHARMACEUTICAL INC reported a net loss of $30.4M in fiscal year 2022. This represents an increase of 28.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2022 through Q3 FY2023, the same line adds up to a $1.1M net loss. The table below carries 6 fiscal years, from 2017 to 2022, and the quarters ARIDIS PHARMACEUTICAL INC has filed alongside them.

FY2022 annual
Net Income -$30.4M
YoY +28.0%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2023, ended Sep 30, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ARDS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Net Income-$1.1M-$30.4M+28.0%-$42.2M-88.9%-$22.3M+24.8%-$29.7M-34.3%-$22.1M+10.3%-$24.7M

TTM is the trailing twelve months, Q4 FY2022 through Q3 FY2023, summed from the four most recent quarterly filings.

ARDS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-QQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-K
Net Income-$83K+99.0%$12.1M+252.2%-$6.8M+12.2%-$6.4M-$8.2M+60.8%-$8.0M-45.3%-$7.8M-12.7%N/A-$21.0M-263.0%-$5.5M-30.1%-$6.9M-6.0%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ARIDIS PHARMACEUTICAL INC financials

Frequently Asked Questions

What was ARIDIS PHARMACEUTICAL INC's net income in fiscal year 2022?

ARIDIS PHARMACEUTICAL INC reported a net loss of $30.4M in fiscal year 2022.

How fast is ARIDIS PHARMACEUTICAL INC's net income growing?

ARIDIS PHARMACEUTICAL INC (ARDS) net income rose by 28.0% year over year, from -$42.2M to -$30.4M in fiscal year 2022.

What is ARIDIS PHARMACEUTICAL INC's net income over the last twelve months?

ARIDIS PHARMACEUTICAL INC (ARDS) reported a $1.1M net loss over the trailing 12 months, Q4 FY2022 through Q3 FY2023, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, ARIDIS PHARMACEUTICAL INC (ARDS) net income went from -$24.7M in fiscal year 2017 to -$30.4M in fiscal year 2022.

ARIDIS PHARMACEUTICAL INC (ARDS) reported -$83K in net income in Q3 2023. This represents an increase of 99.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ARIDIS PHARMACEUTICAL INC (ARDS) reported on that line in every period on record.